Clinical Trials Sponsored by Sucampo AG

Total 2374 results

The University of Texas Health Science Center at...
Institut Straumann AG

Completed

Esthetic, Clinical and Radiographic Outcomes of Immediately Placed Implants (Type 1) and Early Placed Implants (Type 2)

Jaw, Edentulous, Partially | Acquired Absence of Single Tooth

United States
European Organisation for Research and Treatment...
Roche Pharma AG; Amgen

Terminated

Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases (BOS2)

Colorectal Cancer Metastatic | Liver Metastases | KRAS Wild Type Colorectal Cancer

France, Belgium, Austria, Netherlands, Spain, Switzerland
Georg Hess, MD
Roche Pharma AG; Klinikum Frankfurt Höchst

Completed

Rituximab and DexaBEAM as Salvage Therapy for Relapsed Lymphoma (Mz-135)

Relapsed Non-Hodgkin-Lymphoma
Lisa Bax
Roche Pharma AG; Genentech, Inc.

Terminated

Hedgehog Inhibition for Pancreatic Ductal Adenocarcinoma (PDAC) in the Preoperative Setting (HIPPoS) (HIPPoS)

Pancreatic Ductal Adenocarcinoma

United Kingdom
University of Zurich
University Children's Hospital, Zurich; Cereneo AG; ETH Zurich (Switzerland); V...

Recruiting

Precision Sensorimotor Neurorehabilitation Through Personalized Stimulation Loops (StimuLOOP-S)

Stroke

Switzerland
A. Vogel AG
Daacro GmbH & Co. KG, Max-Planck-Str. 22, 54296 Trier/Germany

Not yet recruiting

Sleep Well Observation Study

Sleep Disturbance

Germany
Insel Gruppe AG, University Hospital Bern
Swiss National Science Foundation; Hôpital Fribourgeois; Kantonsspital Baden

Recruiting

An INtervention TO Improve MOBility of Older Hospitalized Patients (INTOMOB)

Iatrogenic Disease | Sarcopenia | Hospital Mobility | Mobility Limitation | Life-Space | Functional Status | Hospital-Acquired Condition | Muscle Atrophy or Weakness

Switzerland
Institut de Recherches Cliniques de Montreal
Pharmascience Inc.; SCiAN Services, Inc.; Quercis Pharma AG

Not yet recruiting

Study of Isoquercetin (IQC-950AN) Plus Standard of Care Versus Standard of Care Only for the Treatment of COVID-19

COVID-19
Medical University of Graz
B. Braun Melsungen AG; Center for Biomarker Research in Medicine

Completed

Investigation of Fluid- and Electrolyte Balance in Post Cardiac-surgery Patients (Clinibil)

Acute Kidney Injury | Electrolyte Imbalances

Austria
University of Aarhus
Mundipharma Pte Ltd.; Roche Pharma AG; Schering-Plough; Nordic Cancer Union

Completed

Nordic Study in Newly Diagnosed Primary Central Nervous System (CNS) Lymphoma

Central Nervous System Lymphoma

Denmark
Latin American Cooperative Oncology Group
Roche Pharma AG; EVA - Grupo Brasileiro de Tumores Ginecológicos

Completed

Prospective Evaluation of Patients With Uterine Cervical Cancer in Brazilian Health Institutions - The EVITA I Study

Cervix Cancer

Brazil
Abramson Cancer Center of the University of Pennsylvania
Bristol-Myers Squibb; Roche Pharma AG

Terminated

Capecitabine,Oxaliplatin & Erbitux Given Throughout Multi-Modal Therapy for Locally Advanced Rectal Adenocarcinoma

Rectal Cancer
Klaus Herfarth, MD
Roche Pharma AG; German Low Grade Lymphoma Study Group

Completed

Rituximab and Involved Field Radiotherapy in Early Stage Follicular Lymphoma (MIR)

Lymphoma, Malignant

Germany
Spanish Cooperative Group for the Treatment of...
Sanofi; Roche Pharma AG

Completed

Study of Bevacizumab Alone or Combined With Capecitabine and Oxaliplatin as Support Therapy in Metastatic Colorectal Cancer Patients

Colorectal Cancer

Spain
University Hospital Inselspital, Berne
PharmaPart; Laboratory: Viollier AG Spalenring 145 / 147 Postfach 4002 Basel

Completed

Atorvastatin 40 mg in Patients With Relapsing-Remitting Multiple Sclerosis Treated With Interferon-Beta-1b (SWABIMS)

Multiple Sclerosis

Switzerland
Amsterdam UMC, location VUmc
Dutch Kidney Foundation; B.Braun Avitum AG; Niercentrum aan de Amstel

Not yet recruiting

The Microcirculation, Dialysis Modality and Sequestered Salt (MIMOSA)

End-stage Renal Disease
Diamontech AG
Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft...

Recruiting

Feasibility of Non-invasive Glucose Monitoring by Using Photothermal Deflectometry

Healthy | Diabetes Mellitus Type 2 | Diabetes Mellitus Type 1

Germany
Université de Sherbrooke
Eli Lilly and Company; Chorus Wellness Inc.; AL-S Pharma AG

Recruiting

Safety and Dosimetry of a New Radiotracer to Detect Misfolded SOD1 Associated With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis

Canada
Insel Gruppe AG, University Hospital Bern
University of Zurich; Cantonal Hospital of St. Gallen

Recruiting

Swiss Diabetes Registry - SwissDiab Study (SwissDiab)

Diabetes Mellitus

Switzerland
Palleos Healthcare GmbH
Roche Pharma AG; Cankado GmbH; WSG WOMEN´S HEALTHCARE STUDY GROUP

Completed

Study to Compare Neoadjuvant Combination of Trastuzumab and Pertuzumab With Concurrent Taxane Chemotherapy or Endocrine Therapy and Quality of Life Assessment Under Adjuvant Therapy in Operable HER2+/HR+ Breast Cancer Patients (TP-II)

Breast Neoplasms

Germany
Instituto Oncológico Dr Rosell
Roche Pharma AG; Fundacion Clinic per a la Recerca Biomédica

Active, not recruiting

Combination of Atezolizumab With Dendritic Cell Vaccine in Patients With Lung Cancer (VENEZO-LUNG)

Extensive-stage Small Cell Lung Cancer

Spain
University of St.Gallen
Swiss National Science Foundation; University hospital of Bern; Sanitas Management...

Completed

The Effect of an Application-based Health Intervention (FoodCoach) on Food Purchases in Switzerland

Adult

Switzerland
Diamontech AG
Institut für Diabetes-Technologie Forschungs- und Entwicklungsgesellschaft...

Terminated

Feasibility Study of Blood Glucose Monitoring With the Non-invasive Medical Device D-Base

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

Germany
Universitat Internacional de Catalunya
Geistlich Pharma AG; BioHorizons, Inc.; Dentsply Sirona Implants and Consumables

Completed

Ridge Preservation in Molar Sites Comparing Xenograft Versus Mineralized Freeze-dried Bone Allograft

Alveolar Ridge Preservation
PIQUR Therapeutics AG
University Hospital Inselspital, Berne; University Hospital, Basel, Switzerland and other collaborators

Terminated

Study to Evaluate the Efficacy, Safety, Pharmacokinetics and Pharmacodynamic Effects of PQR309 in Glioblastoma Patients

Glioblastoma Multiforme

Switzerland
The HIV Netherlands Australia Thailand Research...
Roche Pharma AG; Ministry of Health, Thailand

Completed

Efficacy and Safety of SQV in Patients Who Have Chronic IDV Nephrotoxicity

IDV Associated Nephrotoxicity

Thailand
iOMEDICO AG
Merck Sharp & Dohme LLC; Arbeitsgemeinschaft fur Internistische Onkologie; Arbeitskreis... and other collaborators

Completed

Epidemiological EMESIS-Registry (EMESIS)

Antiemetic Therapy

Germany
Oogziekenhuis Rotterdam
Carl Zeiss Meditec AG; Stichting Wetenschappelijk Onderzoek Het Oogziekenhuis...

Recruiting

Microinterventional Endocapsular Nuclear Fragmentation Assisted Cataract Surgery

Nuclear Cataract

Netherlands
Insel Gruppe AG, University Hospital Bern
University Hospital, Basel, Switzerland; Cardiocentro Ticino; Triemli Hospital

Recruiting

Prediction of Reverse Remodeling and Outcome in Patients With Severe Secondary Mitral Valve Regurgitation Undergoing Transcatheter Edge-to-edge Mitral Valve Repair (PRE-MITRA)

Severe Mitral Regurgitation

Switzerland
Michael Rufer
University of Zurich

Enrolling by invitation

Integrated Care After Repeated Psychiatric Hospital Stays - Evaluation of an Interdisciplinary Treatment Program (INTUK)

Health Care Utilization | Chronic Psychiatric Disorder | Psychiatric Hospitalization | Intensive Care Psychiatric Disorder | Rehospitalization | High Utilization / Heavy Use

Switzerland
Medicos e Investigadores en la Lucha contra el...
Roche Pharma AG

Completed

Randomized and Multicenter Study to Evaluate a Customizable Support Breast Cancer Material

Breast Cancer | Patient Satisfaction | Knowledge, Attitudes, Practice | Patient Empowerment

Mexico
Philipps University Marburg Medical Center
Deutsche Krebshilfe e.V., Bonn (Germany); AOP Orphan Pharmaceuticals AG

Completed

ENDURE - Efficacy and Safety of AOP2014 With CML Patients in Remission (ENDURE-CML-IX)

Chronic Myeloid Leukemia in Remission

France, Germany
University of Ulm
AbbVie; Roche Pharma AG; Janssen-Cilag Ltd.; German CLL Study Group

Completed

Trial of Ibrutinib Plus Venetoclax Plus Obinutuzumab in Patients With CLL (CLL2-GiVe)

Leukemia, Lymphocytic, Chronic

Germany
University of Zurich
Swiss Federal Institute of Technology in Zurich (ETH Zurich); Tyromotion AG

Completed

Encouragement-induced Movement Therapy in Daily Life (ISEAR)

Stroke

Switzerland
Aarhus University Hospital
Odense University Hospital; Roche Pharma AG; Herning Hospital; Aalborg University...

Unknown

Blood Sample Monitoring of Patients With EGFR Mutated Lung Cancer

Lung Neoplasms

Denmark
Gabi Chiorean, MD
Pfizer; Roche Pharma AG; Walther Cancer Institute

Terminated

Capecitabine + Irinotecan Followed by Combined Modality Capecitabine and Radiation in Locally Advanced Rectal Cancer

Rectal Cancer

United States
Centre Hospitalier Universitaire Vaudois
Ecole Polytechnique Fédérale de Lausanne; Insel Gruppe AG, University Hospital...

Recruiting

Potentiated Aminoglycosides in Postoperative Urinary Tract Infection Prophylaxis (UROPOT)

Urinary Tract Infections | Urological System Complication of Procedure

Switzerland
Prof. Wolfgang Janni
Roche Pharma AG; Novartis Pharmaceuticals; Celgene Corporation; Eisai GmbH

Active, not recruiting

Detect V / CHEVENDO (Chemo vs. Endo)

Metastatic Breast Cancer

Germany
University of Illinois at Chicago
National Heart, Lung, and Blood Institute (NHLBI); Roche Pharma AG

Completed

Patient-Centered Anticoagulation Self-Monitoring in Minority Patients

Cardiovascular Disease | Blood Coagulation Disorders | Thromboembolism | Vascular Disease

United States
Royal Marsden NHS Foundation Trust
Pfizer; Roche Pharma AG; Institute of Cancer Research, United Kingdom

Unknown

PIPA: Combination of PI3 Kinase Inhibitors and PAlbociclib (PIPA)

Breast Cancer | Advanced Solid Tumours

United Kingdom
University Hospital, Brest
Novartis; Roche Pharma AG; Ministry of Health, France; Genzyme, a Sanofi Company

Completed

mTor-inhibitor (EVERolimus) Based Immunosuppressive Strategies for CNI Minimisation in OLD for Old Renal Transplantation (EVEROLD)

Renal Transplant

France
University Hospital Inselspital, Berne
Brahms AG; Foundation for research in Anaesthesie and Intensive Care Medicine

Completed

Electrolyte and Fluid Disturbances in Subarachnoid Hemorrhage and Traumatic Brain Injury

Traumatic Brain Injury | Subarachnoid Hemorrhage | Natriuretic Peptides | Electrolyte Disturbances

Switzerland
University of Liverpool
Roche Pharma AG; Cancer Research UK; Liverpool University Hospitals NHS Foundation...

Unknown

A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients (PACIFICO)

Follicular Lymphoma

United Kingdom
Assistance Publique - Hôpitaux de Paris
Fondation Francophone pour la Recherche sur le Diabete; Ypsomed AG

Not yet recruiting

Evaluation of Neurodevelopmental Trajectories in Children According to the Glycemic Profile Associated With Different Early Treatment Modalities in Children With Type 1 Diabetes (T1DM) (PROCEDE)

Diabetes
Insel Gruppe AG, University Hospital Bern
University Hospital, Basel, Switzerland; University Hospital, Zürich; Stadtspital...

Not yet recruiting

Administration of Intranasal Midazolam for Anxiety in Palliative Care (AIM Care)

Anxiety | Acute Anxiety

Switzerland
Institut für Klinische Krebsforschung IKF GmbH...
Roche Pharma AG; Thoraxklinik-Heidelberg gGmbH

Recruiting

NeoTRACK - Dissection of IO Efficacy in NSCLC by Longitudinal tracKing

Non-small Cell Lung Cancer

Germany
Glenn J. Hanna
Adenoid Cystic Carcinoma Research Foundation; Cellestia Biotech AG

Recruiting

CB-103 With Either Lenvatinib or Abemaciclib in Patients With NOTCH ACC

Adenoid Cystic Carcinoma | Metastatic Adenoid Cystic Carcinoma | Recurrent Adenoid Cystic Carcinoma

United States
University Hospital, Antwerp
Roche Pharma AG; Algemeen Ziekenhuis Maria Middelares; Kom Op Tegen Kanker; Vitaz

Recruiting

Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma (Immuno-MESODEC)

Malignant Pleural Mesothelioma

Belgium
Centre Hospitalier Universitaire Vaudois
Hôpital Riviera-Chablais, Vaud-Valais; Insel Gruppe AG, University Hospital...

Recruiting

The Role of Preoperative Immunonutrition on Morbidity and Immune Response After Cystectomy (INCyst Trial) (INCyst)

Endometriosis | Bladder Cancer | Interstitial Cystitis | Neurogenic Bladder | Bladder Disease | Painful Bladder Syndrome | Hemorrhagic Cystitis

Switzerland
A. Vogel AG
Medical University of Graz; MediStat Ltd.; Biodome Clinical; Clinical Research...

Recruiting

Echinaforce COVID-19 Shedding Study

SARS-CoV2 Infection | COVID-19 Respiratory Infection

Bulgaria

Clinical Trials Sponsored by Sucampo AG

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations